Compare BANC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BANC | TMDX |
|---|---|---|
| Founded | 1941 | 1998 |
| Country | United States | United States |
| Employees | 1904 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | N/A | 2019 |
| Metric | BANC | TMDX |
|---|---|---|
| Price | $20.56 | $67.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $21.83 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 2.9M | 1.2M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $13.93 | $24.25 |
| Revenue Next Year | $8.03 | $18.75 |
| P/E Ratio | ★ $17.08 | $332.10 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $13.96 | $60.11 |
| 52 Week High | $21.61 | $156.00 |
| Indicator | BANC | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 61.09 | 40.98 |
| Support Level | $19.40 | $64.90 |
| Resistance Level | $21.43 | $71.14 |
| Average True Range (ATR) | 0.41 | 4.14 |
| MACD | 0.02 | -0.32 |
| Stochastic Oscillator | 68.63 | 19.65 |
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.